BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chhabra N, Kennedy J. A Review of Cancer Immunotherapy Toxicity II: Adoptive Cellular Therapies, Kinase Inhibitors, Monoclonal Antibodies, and Oncolytic Viruses. J Med Toxicol 2021. [PMID: 33821435 DOI: 10.1007/s13181-021-00835-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang A, Yang F, Gao L, Shi X, Yang J. Research Progress on Radiotherapy Combined with Immunotherapy for Associated Pneumonitis During Treatment of Non-Small Cell Lung Cancer. Cancer Manag Res 2022;14:2469-83. [PMID: 35991677 DOI: 10.2147/CMAR.S374648] [Reference Citation Analysis]
2 Orzetti S, Tommasi F, Bertola A, Bortolin G, Caccin E, Cecco S, Ferrarin E, Giacomin E, Baldo P. Genetic Therapy and Molecular Targeted Therapy in Oncology: Safety, Pharmacovigilance, and Perspectives for Research and Clinical Practice. Int J Mol Sci 2022;23:3012. [PMID: 35328435 DOI: 10.3390/ijms23063012] [Reference Citation Analysis]
3 van Vliet AA, Georgoudaki AM, Raimo M, de Gruijl TD, Spanholtz J. Adoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic Melanoma. Cancers (Basel) 2021;13:4722. [PMID: 34572949 DOI: 10.3390/cancers13184722] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
4 Syama K, Hassan EM, Zou S. Advances in culture methods for acute myeloid leukemia research. Oncoscience 2021;8:82-90. [PMID: 34368398 DOI: 10.18632/oncoscience.540] [Reference Citation Analysis]
5 Dixon ML, Leavenworth JD, Leavenworth JW. Lineage Reprogramming of Effector Regulatory T Cells in Cancer. Front Immunol 2021;12:717421. [PMID: 34394124 DOI: 10.3389/fimmu.2021.717421] [Cited by in F6Publishing: 2] [Reference Citation Analysis]